Corporate News

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces its final results for the year ended 31 December 2023, a pivotal year in which the Company launched its range of at home Wellness tests in Boots, the UK’s largest pharmacy retailer

Download To view a full version of the results in  PDF format  click here

 

Financial highlights

• Revenue of £11.0m (2022: £22.3m)
• Adjusted EBITDA of £0.015m (2022: £2.26m)
• Cash balance at year end of £7.75m (2022: £7.61m)
• Strong cash position to ensure next growth phase remains self-funded

Commercial and operational highlights

•  Retail launch of 21 tests in Boots, the UK’s largest pharmacy retailer
• Ongoing strong relationship with Boots
• Sustained unit sales growth of Wellness portfolio since launch
• Achievement of Healthcare Inspectorate Wales Certification
• Migration to Digital Quality Management System (“QMS”)
• Self-funded ongoing digital enhancements and investment in compliance and governance

The full Group Annual Report and Audited Financial Statements will be posted to shareholders today and will also be available shortly at www.investors.myhealthcheckedplc.com.

Penny McCormick, Chief Executive Officer of MyHealthChecked PLC, said: “2023 was a pivotal year for MyHealthChecked as the Company’s focus moved to our Wellness test portfolio. We launched 23 tests, of which 21 are now available in Boots stores and online and we have seen over 45% increase in unit sales since Q4 2023. All of this would not have been possible without the revenue generated from COVID testing in prior years which has allowed us to implement a clear strategy, creating future growth opportunities and longevity for MyHealthChecked.

“The Company is now in a strong position with sufficient working capital available to fund the next growth phase as we continue to prioritise quality and customer service to become a leading supplier in the wellness testing sector. I would like to thank the MyHealthChecked team for their continued hard work over the last year and our shareholders for their ongoing support.”

Investor presentation

Penny McCormick, Chief Executive Officer, Lesley Innes, Chief Financial Officer, and Adam Reynolds, Non-executive Chairman will provide a live presentation relating to the final results via the Investor Meet Company platform today (Tuesday 4 June 2024) at 16:00 BST. The presentation is open to all existing and potential shareholders.

Investors can sign up to Investor Meet Company for free and register for the presentation via the link below:

https://www.investormeetcompany.com/myhealthchecked-plc/register-investor

Notice of Annual General Meeting

The Annual General Meeting (AGM) will be held at 10.30 a.m. on 28 June 2024 in the Castle Room at The Maltings, East Tyndall Street, Cardiff, CF24 5EA. The full notice will be available shortly on the Company website here:

 www.investors.myhealthcheckedplc.com.

Only registered shareholders are entitled to attend the AGM. Any shareholders who wish to attend the meeting should email [email protected] with their proof of shareholding to register for the meeting.

 

For further information contact:

MyHealthChecked PLC	www.myhealthchecked.com
Penny McCormick, Chief Executive Officer	via Walbrook PR
SPARK Advisory Partners Limited (NOMAD)	Tel: +44 (0)20 3368 3550
Neil Baldwin / Jade Bayat
Dowgate Capital Limited (Broker)	Tel: +44 (0)20 3903 7715
David Poutney / Nicholas Chambers
Walbrook PR Ltd (Media & IR)	Tel: +44 (0)20 7933 8780 or [email protected]
Paul McManus / Alice Woodings	Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

 

About MyHealthChecked PLC (www.myhealthcheckedplc.com)

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.